학술논문
Phase 3 Safety and Efficacy of AZD1222 (CHADOX1 NCoV-19) Covid-19 Vaccine
Document Type
Article
Author
Falsey, A.R.; Keefer, M.C.; Sobieszczyk, M.E.; Mulligan, M.J.; Hirsch, I.; Green, J.A.; Marshall, R.P.; Pangalos, M.N.; Sproule, S.; Shoemaker, K.; Maaske, J.; Takas, T.; Villafana, T.; Gonzalez-Lopez, A.; Kelly, E.J.; Mueller, N.; Robb, M.L.; Neuzil, K.M.; Durbin, A.; Cowden, J.; Tong, T.; Isaacs, M.B.; Nason, M.C.; Corey, L.; Hahn, W.; Hunt, J.; Janes, H.E.; McEvoy, C.; DeJesus, E.; Bush, L.; Hassman, M.; Little, S.J.; Daar, E.S.; Buchbinder, S.; Pahud, B.A.; Pickrell, P.; Solis, J.; Carr, Q.O.; Oyedele, T.; Vargas, S.L.; Benavides, A.G.; Call, R.; Kirkpatrick, B.D.; Pullman, J.; Benkeser, D.
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 16 December 2021, 385(25):2348-2360)
Subject
Language
English
ISSN
15334406
00284793
00284793